214 related articles for article (PubMed ID: 19492956)
21. Prospective randomized comparison of 1-day versus 3-day application of topical levofloxacin in eliminating conjunctival flora.
Ta CN; Sinnar S; He L; Myung D; Miño De Kaspar H
Eur J Ophthalmol; 2007; 17(5):689-95. PubMed ID: 17932841
[TBL] [Abstract][Full Text] [Related]
22. [Efficacy of topical povidone-iodine applied the day before cataract surgery to reduce conjunctival flora].
González Bandrés C; Carrilero Ferrer MJ; Buznego Suárez L; García Claramunt MA; Méndez Llata M; Paredes B; Moriche Carretero M
Arch Soc Esp Oftalmol; 2001 Apr; 76(4):229-34. PubMed ID: 11340513
[TBL] [Abstract][Full Text] [Related]
23. Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection.
Milder E; Vander J; Shah C; Garg S
Ophthalmology; 2012 Jul; 119(7):1420-4. PubMed ID: 22420958
[TBL] [Abstract][Full Text] [Related]
24. [Comparative study of gentamycin and povidone-iodine on eliminating the conjunctival bacteria].
Shi MH; Hu N; Guan HJ; Ye YJ; Chen MS; Yu CT
Zhonghua Yan Ke Za Zhi; 2008 Dec; 44(12):1098-102. PubMed ID: 19187664
[TBL] [Abstract][Full Text] [Related]
25. Application of 10% povidone iodine reduces conjunctival bacterial contamination rate in patients undergoing cataract surgery.
Nentwich MM; Rajab M; Ta CN; He L; Grueterich M; Haritoglou C; Gandorfer A; Kampik A; Mino De Kaspar H
Eur J Ophthalmol; 2012; 22(4):541-6. PubMed ID: 22180155
[TBL] [Abstract][Full Text] [Related]
26. Microbiota evaluation of patients with a Boston type I keratoprosthesis treated with topical 0.5% moxifloxacin and 5% povidone-iodine.
Magalhães FP; do Nascimento HM; Ecker DJ; Sannes-Lowery KA; Sampath R; Rosenblatt MI; de Sousa LB; de Oliveira LA
Cornea; 2013 Apr; 32(4):407-11. PubMed ID: 22488148
[TBL] [Abstract][Full Text] [Related]
27. The effect of povidone iodine flush versus drops on conjunctival colonization before intravitreal injections.
Safar A; Dellimore MC
Int Ophthalmol; 2007 Oct; 27(5):307-12. PubMed ID: 17440685
[TBL] [Abstract][Full Text] [Related]
28. Conjunctival concentrations of a new ophthalmic solution formulation of moxifloxacin 0.5% in cataract surgery patients.
Lindstrom R; Lane S; Cottingham A; Smith S; Sall K; Silverstein S; Shettle L; Walters T; Faulkner R; Cockrum P; Teuscher N
J Ocul Pharmacol Ther; 2010 Dec; 26(6):591-5. PubMed ID: 20925517
[TBL] [Abstract][Full Text] [Related]
29. Moxifloxacin punctum plug for sustained drug delivery.
Chee SP
J Ocul Pharmacol Ther; 2012 Aug; 28(4):340-9. PubMed ID: 22191856
[TBL] [Abstract][Full Text] [Related]
30. Comparative efficacy of two different topical povidone-iodine 5% regimens in reducing conjunctival bacterial flora: A randomized parallel double-masked clinical trial.
Barroso LF; Cazella SP; Nepomuceno AB; Toscano L; Castilho LÂS; Furlan EMR; Messias A; Scott IU; Jorge R
PLoS One; 2017; 12(12):e0189206. PubMed ID: 29261737
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis.
McDonald MB; Protzko EE; Brunner LS; Morris TW; Haas W; Paterno MR; Comstock TL; Usner DW
Ophthalmology; 2009 Sep; 116(9):1615-1623.e1. PubMed ID: 19643483
[TBL] [Abstract][Full Text] [Related]
32. Antibiotic susceptibility of conjunctival bacterial isolates from refractive surgery patients.
Chung JL; Seo KY; Yong DE; Mah FS; Kim TI; Kim EK; Kim JK
Ophthalmology; 2009 Jun; 116(6):1067-74. PubMed ID: 19395038
[TBL] [Abstract][Full Text] [Related]
33. Comparing the effectiveness of moxifloxacin and povidone-iodine with povidone-iodine alone.
Balzli CL; Caballero AR; O'Callaghan RJ
J Cataract Refract Surg; 2010 May; 36(5):871; author reply 871-2. PubMed ID: 20457392
[No Abstract] [Full Text] [Related]
34. Susceptibility comparisons of normal preoperative conjunctival bacteria to fluoroquinolones.
Hori Y; Nakazawa T; Maeda N; Sakamoto M; Yokokura S; Kubota A; Inoue T; Nishida K; Tano Y
J Cataract Refract Surg; 2009 Mar; 35(3):475-9. PubMed ID: 19251140
[TBL] [Abstract][Full Text] [Related]
35. Ophthalmic antibiotic use and multidrug-resistant staphylococcus epidermidis: a controlled, longitudinal study.
Dave SB; Toma HS; Kim SJ
Ophthalmology; 2011 Oct; 118(10):2035-40. PubMed ID: 21856006
[TBL] [Abstract][Full Text] [Related]
36. The effect of topical povidone-iodine, intraocular vancomycin, or both on aqueous humor cultures at the time of cataract surgery.
Mendivil Soto A; Mendivil MP
Am J Ophthalmol; 2001 Mar; 131(3):293-300. PubMed ID: 11239859
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of topical povidone-iodine during the first week after ophthalmic surgery.
Isenberg SJ; Apt L; Yoshimori R; Pham C; Lam NK
Am J Ophthalmol; 1997 Jul; 124(1):31-5. PubMed ID: 9222229
[TBL] [Abstract][Full Text] [Related]
38. Topical ophthalmic moxifloxacin elicits minimal or no selection of fluoroquinolone resistance among bacteria isolated from the skin, nose, and throat.
Lichtenstein SJ; De Leon L; Heller W; Marshall B; Cupp G; Foster K; McLean C; Levy S; Stroman DW
J Pediatr Ophthalmol Strabismus; 2012; 49(2):88-97. PubMed ID: 22074357
[TBL] [Abstract][Full Text] [Related]
39. Effects of topical azithromycin, moxifloxacin, and povidone iodine on conjunctival bacterial flora in patients undergoing intravitreal injection.
Teberik K; Eski MT; Çalışkan E; Kılınçel Ö; Kaya M; Ankaralı H
Arq Bras Oftalmol; 2019; 82(1):25-31. PubMed ID: 30652764
[TBL] [Abstract][Full Text] [Related]
40. Study of the Acute Effects of Povidone-Iodine on Conjunctival Bacterial Flora.
Pettey JH; Mifflin MD; Olson RJ
J Ocul Pharmacol Ther; 2015 Dec; 31(10):627-30. PubMed ID: 26287981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
